A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.

Wound dressings including activated carbon cloth or a fabric, cloth, or other flexible material containing activated carbon and methods for manufacturing and using such wound dressings to effectuate healing of wounds on humans or other animals are described herein.

Provided is a charcoal dressing material and a method of manufacturing the same. The charcoal dressing material includes: a porous substrate having a plurality of pores; and a charcoal powder adhered to a surface of the porous substrate.

The present invention relates to an activated composition comprising a spherical activated carbon particle of a sphericity greater than 0.6 and at least one of a plurality of possible active agents. The composition effectively sequesters the malodors, which includes complex fishy smell containing no amines, sulfur-containing malodors, and volatile organic compounds such as formaldehyde, volatile aldehydes, and ethylene. The activated composition of the present invention may be useful in consumer, personal care, home care, and healthcare-related products and industrial applications.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and wherein at least the adhesive includes a water gradient silicone hydrogel.

Systems, devices, methods, and compositions are described for providing an actively controllable implant configured to, for example, monitor, treat, or prevent microbial growth or adherence to the implant.

A conductive hydrogel precursor solution cures after injection into the vasculature of the myocardium. The vasculature acts as a mold for the hydrogel and allows for a pacing signal to be conducted across the myocardium and not at a single point like traditional pacing leads. The catheter-based delivery can accurately place the hydrogels into the myocardial veins and can fill the venous tributaries. In situ crosslinking of the hydrogel precursor solution is achieved through several mechanisms, such as redox initiation by mixing a reducing reagent and oxidizing agent after injection. Conductivity is achieved by doping in conductive polymers or other conductive elements such as ionic species, metallic nanoparticles, or graphene nanoplatelets. To ensure long-term conductivity, hydrogel macromers may be synthesized without hydrolytically labile groups such as esters, and the conductive elements may be conjugated directly to the hydrogel matrix.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.